ACADIA Pharmaceuticals Inc (ACAD)

39.88 -0.35  -0.87% NASDAQ Aug 12, 16:59 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
10/30/2020 16:30 EDT Misc ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020
10/30/2020 Earnings ACADIA Pharmaceuticals Inc Third Quarter Earnings for 2020 Release
08/05/2020 16:30 EDT Misc ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings ACADIA Pharmaceuticals Inc Second Quarter Earnings Result for 2020
06/23/2020 08:00 PDT Misc ACADIA Pharmaceuticals Inc Annual General Meeting for 2019
05/07/2020 16:30 EDT Misc ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
05/07/2020 Earnings ACADIA Pharmaceuticals Inc First Quarter Earnings Result for 2020
02/27/2020 Misc ACADIA Pharmaceuticals Inc Annual Report for 2019
02/26/2020 17:00 EST Misc ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
02/26/2020 Earnings ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.acadia-pharm.com
  • Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Oct. 30, 2020
  • Last Earnings Release: Aug. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Top Fund Holders

Symbol Name Weighting
ASYMX Alger Weatherbie Specialized Growth Y 2.58%
BTEC Principal Healthcare Innovators ETF 1.45%
FBIOX Fidelity® Select Biotechnology 1.35%
CEARX Columbia Acorn Adv 1.34%
TDB875 TD Health Sciences Fund - O 1.20%
HQL Tekla Life Sciences Investors 1.01%
HQH Tekla Healthcare Investors 0.84%
FGKFX Fidelity® Growth Company K6 0.73%
FSSNX Fidelity® Small Cap Index 0.33%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.